News

Genoskin at the European Mast Cell and Basophil Research Network meeting in ToulouseAdvancing mast cell research through in vitro evaluation of mast cell responsesWe are thrilled to announce our participation in the prestigious European Mast cell and Basophil Research Network (EMBRN) Conference, set to take place in Genoskin’s hometown, Toulouse, France, from May 29-31, 2024. This event will bring togetherRead more

Thank you for your interest in our webinar on the dual role of mast cells, titled "Mast Cells: Can't live with them, can't live without them?". Below, you will find the questions we did not have time to address during the live session with Dr. Marcus Maurer. Q: In cold activated urticaria, is some of it caused by clonotypic IgE whichRead more

Genoskin at the World Vaccine CongressAdvancing Vaccine Research with High-Dimensional Immune ProfilingFrom April 1-4, 2024, the global vaccine community gathered for the World Vaccine Congress in Washington, D.C. Taking place at the heart of the nation's capital, the congress was a cornerstone event for vaccine professionals worldwide, offering a platform for sharing groundbreaking research, fostering collaborations, and exploring the latestRead more

Top-level science through the eyes of an expert.The seventh Webinar. The seventh webinar in the Naked Immunology series is now scheduled on April 8, 2024 at 8 a.m. (PST), 11 a.m. (EST), 5 p.m. (CET). The webinar is open to English-speaking participants with a solid scientific background. Featured speaker is Dr. Marcus Maurer, MD, Professor of Dermatology and Allergy, Co‐DirectorRead more

The Silent Crisis in Biomedical Research: Beyond MacaquesFinding an alternative to non-human primates to evaluate human therapeutics In a compelling narrative echoed by Le Monde, the biomedical sector faces a silent crisis, highlighting the geopolitical intricacies and ethical quandaries of scientific research. At its core, the dwindling supply of non-human primates (NHPs), particularly macaques, essential for testing medical treatments, hasRead more

Immunogenicity SeriesPart 2 - Wanted Immunogenicity for Vaccine DevelopmentImmunogenicity is a key concept in vaccine development,referring to the ability of a vaccine to stimulate an immune response in the recipient. It is a desirable and critical characteristic because the effectiveness of a vaccine is directly linked to its ability to induce a robust and protective immune response. Vaccine Development: GlobalRead more